Media
News
Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.
Bayer Crop Science Canada Launches EverGol Rise for Enhanced User Experience in Pulse Disease Control
Bayer Crop Science Canada Expands Herbicide Solutions Huskie® PRE and Velocity® m3 in Eastern Canada
Bayer Inc. announced that JIVI® (Antihemophilic Factor [Recombinant, B-domain deleted, PEGylated]) is now authorized for use in patients 7 to under 12 years of age with hemophilia A (congenital Factor VIII deficiency).
Bayer Canada Announces New Distribution Partnership for ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in Canada
Health Canada grants marketing authorization for an additional indication of Bayer’s NUBEQA® (darolutamide) for the treatment of metastatic castration-sensitive prostate cancer (mCSPC)